1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal DegenerationBardet-Biedl syndrome 1, Eye Diseases, Hereditary, eye disorder, retinal degeneration, retinal disorderRecruitingEarly phase 12026-08-04NCT07269665